A frontal brain region may be a potential biomarker for the early stages of nicotine addiction

In a recent article published in Nature Communications, researchers examined the distinct roles of left and right ventromedial prefrontal cortex (vmPFC) gray matter volume (GMV) in initiating and sustaining smoking behavior among young adolescents.

Association between vmPFC gray matter volume and smoking initiation in adolescents
Study: Association between vmPFC gray matter volume and smoking initiation in adolescents. Image Credit:SpeedKingz/Shutterstock.com

The team used cross-lagged longitudinal analysis and Mendelian randomization analysis to pursue evidence that vmPFC GMV is an early-stage biomarker of nicotine addiction.

Background

Of all addictive behaviors, cigarette smoking is the most prevalent worldwide and a leading cause of adult mortality.

Several preclinical and in-human studies have shown that nicotine exposure during adolescence increases the risk of nicotine dependence by age 18, while teenage non-smokers are not likely to develop dependence. Quitting is notoriously difficult for adolescent smokers.

So far, clinical interventions have focused on chronic addicts, even though there is a much larger population with pre-addiction. Hence, there is a need to find and elucidate the biological underpinnings of the initiation and sustenance of smoking behavior during adolescence.

During the adolescence to early adulthood phase, the growth curve of brain GMV attains a peak, including peak axon myelination and synaptic pruning. While occurring throughout adolescence, these brain maturational processes cause brain re-organization, which improves adaptive behavior, such as risky decision-making. 

Previous studies have implicated the prefrontal cortex (PFC) to risk adjustment responses as it develops structurally and functionally during adolescence. Any disruption in the development of such critical neural networks, such as vmPFC, a key node in the cortico-mesolimbic dopaminergic system, could disturb some critical aspects of cognitive function, such as risk adjustment giving rise to maladaptive behaviors, such as addiction. 

Yet, researchers have not reached a consensus regarding an association between brain development changes and smoking during adolescence, and biological mechanisms governing these processes also remain elusive.

About the study

In the present study, researchers analyzed the large dataset from the IMAGEN project, a longitudinal neuroimaging genetic study conducted among 2000 healthy adolescents.

First, they assessed their neuroimaging and behavioral data at ages 14 (baseline), followed up with subsequent follow-ups at ages 19 and 23.

Next, they used the European School Survey Project on Alcohol and Other Drugs (ESPAD) scores to measure each participant's smoking status at each time point, where a score of >0 indicated they were smokers.

The team had structural images and behavioral scores of 807 participants (55% females) at baseline and follow-up, of which 181 participants smoked before the baseline interview. Of these, 166 participants (over 50%) continued smoking at follow-ups. The remaining 260 and 366 participants comprised the control and follow-up smoker groups (FU-S) respectively.

Results

The study results showed that reduced GMV in the left vmPFC was associated with increased rule-breaking about smoking. The reduced GMV in the right vmPFC further strengthened smoking behavior by heightening the hedonic aspect of the smoking experience. In other words, an accumulation of hedonic experiences led to the reinforcement of addictive behavior.

Environmental factors, for example, parental smoking, were not associated with GMV in the left vmPFC at baseline, thus indicating its independent contributions. Therefore, adolescents with smaller left vmPFC could potentially require additional social support in order to lessen their exposure to risky environments.

Further, it is suggested that non-drug rewards at the early stage of substance use could potentially aid the prevention of a transition to substance dependency.

Based on these observations, the authors proposed a reinforcement loop underlying the sustenance of smoking, where smoking behavior could reduce GMV in the right vmPFC, leading to uninhibited, higher sensation seeking, thus, further promoting future smoking behavior.

Psychotropic drugs that preserve GMV in the right vmPFC or enhance its function could be potential treatments for addiction.

Conclusions

The reduction in the left vmPFC GMV had a possible causal influence on rule-breaking behavior that potentially led to the initiation of substance use.

Subsequently, the substance-induced changes in the right vmPFC GMV modulated hedonic effects of substance use for future substance use sustenance.

Overall, this study painted a possible causal account of how nicotine abuse starts and becomes an addiction. More importantly, it highlighted how interventions targeting the early stages of nicotine addiction during adolescence could prove highly beneficial.

Journal reference:
Neha Mathur

Written by

Neha Mathur

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mathur, Neha. (2023, August 21). A frontal brain region may be a potential biomarker for the early stages of nicotine addiction. News-Medical. Retrieved on November 24, 2024 from https://www.news-medical.net/news/20230821/A-frontal-brain-region-may-be-a-potential-biomarker-for-the-early-stages-of-nicotine-addiction.aspx.

  • MLA

    Mathur, Neha. "A frontal brain region may be a potential biomarker for the early stages of nicotine addiction". News-Medical. 24 November 2024. <https://www.news-medical.net/news/20230821/A-frontal-brain-region-may-be-a-potential-biomarker-for-the-early-stages-of-nicotine-addiction.aspx>.

  • Chicago

    Mathur, Neha. "A frontal brain region may be a potential biomarker for the early stages of nicotine addiction". News-Medical. https://www.news-medical.net/news/20230821/A-frontal-brain-region-may-be-a-potential-biomarker-for-the-early-stages-of-nicotine-addiction.aspx. (accessed November 24, 2024).

  • Harvard

    Mathur, Neha. 2023. A frontal brain region may be a potential biomarker for the early stages of nicotine addiction. News-Medical, viewed 24 November 2024, https://www.news-medical.net/news/20230821/A-frontal-brain-region-may-be-a-potential-biomarker-for-the-early-stages-of-nicotine-addiction.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Marijuana use linked to elevated nicotine levels in plastic surgery patients